{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:53:06Z","timestamp":1760122386092},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Kyowa Hakko Kirin Co., Ltd., Japan"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.antiviral.2014.08.016","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T03:48:52Z","timestamp":1410839332000},"page":"60-68","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Evaluation of a fully human monoclonal antibody against multiple influenza A viral strains in mice and a pandemic H1N1 strain in nonhuman primates"],"prefix":"10.1016","volume":"111","author":[{"given":"Aihua","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Myojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Laudenslager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Kuni-Kamochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Soloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinya","family":"Ohgami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.08.016_b0005","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/AAC.49.2.556-559.2005","article-title":"Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations","volume":"49","author":"Abed","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.08.016_b0010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1743-422X-6-224","article-title":"Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein","volume":"6","author":"Beerli","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2014.08.016_b0015","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.295.8.joc60020","article-title":"Adamantane resistance among influenza A viruses isolated early during the 2005\u20132006 influenza season in the United States","volume":"295","author":"Bright","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2014.08.016_b0020","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1073\/pnas.111165798","article-title":"Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes","volume":"98","author":"Brown","year":"2001","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2014.08.016_b0025","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/nature06956","article-title":"Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants","volume":"453","author":"Collins","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.08.016_b0030","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI41902","article-title":"Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine","volume":"120","author":"Corti","year":"2010","journal-title":"The J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2014.08.016_b0035","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.08.016_b0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.virol.2005.04.004","article-title":"Universal influenza A vaccine: optimization of M2-based constructs","volume":"337","author":"De Filette","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.08.016_b0045","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa054512","article-title":"Oseltamivir resistance during treatment of influenza A (H5N1) infection","volume":"353","author":"de Jong","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.08.016_b0050","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.vaccine.2008.04.052","article-title":"Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform","volume":"26","author":"Denis","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.08.016_b0055","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.08.016_b0060","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.08.016_b0065","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2004.02.021","article-title":"Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys","volume":"22","author":"Fan","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.08.016_b0070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virusres.2004.02.030","article-title":"A \u201cuniversal\u201d human influenza A vaccine","volume":"103","author":"Fiers","year":"2004","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2014.08.016_b0075","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1073\/pnas.0911806107","article-title":"Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses","volume":"107","author":"Grandea","year":"2010","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2014.08.016_b0080","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1177\/0300985810374836","article-title":"Pandemic 2009 H1N1 influenza virus causes diffuse alveolar damage in cynomolgus macaques","volume":"47","author":"Herfst","year":"2010","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.antiviral.2014.08.016_b0085","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1084\/jem.20030351","article-title":"A critical role for OX40 in T cell-mediated immunopathology during lung viral infection","volume":"198","author":"Humphreys","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2014.08.016_b0090","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.2165\/11531450-000000000-00000","article-title":"Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses","volume":"69","author":"Hurt","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2014.08.016_b0095","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2014.08.016_b0100","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2014.08.016_b0105","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.08.016_b0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.micinf.2004.10.006","article-title":"Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design","volume":"7","author":"Liu","year":"2005","journal-title":"Microbes Infect."},{"key":"10.1016\/j.antiviral.2014.08.016_b0115","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.08.016_b0120","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1158\/1078-0432.CCR-04-1867","article-title":"Enhanced apoptosis and tumor regression induced by a direct agonist antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2","volume":"11","author":"Motoki","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.antiviral.2014.08.016_b0125","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0264-410X(03)00040-9","article-title":"Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2","volume":"21","author":"Mozdzanowska","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.08.016_b0130","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1158\/0008-5472.CAN-07-6297","article-title":"Engineered antibodies of IgG1\/IgG3 mixed isotype with enhanced cytotoxic activities","volume":"68","author":"Natsume","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2014.08.016_b0135","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2014.08.016_b0140","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/JVI.69.4.2075-2081.1995","article-title":"Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice","volume":"69","author":"Palladino","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.08.016_b0145","first-page":"877","article-title":"Clinical, laboratory, and radiologic characteristics of confirmed avian influenza (H5N1).","volume":"43","author":"Prawira","year":"2012","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"issue":"Pt 7","key":"10.1016\/j.antiviral.2014.08.016_b0150","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1099\/0022-1317-77-7-1483","article-title":"The immunological activity of a deletion mutant of influenza virus hemagglutinin lacking the globular region","volume":"77","author":"Sagawa","year":"1996","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2014.08.016_b0155","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3109\/02770903.2013.834505","article-title":"Asthma and severity of 2009 novel H1N1 influenza: a population-based case-control study","volume":"50","author":"Santillan Salas","year":"2013","journal-title":"J. Asthma"},{"key":"10.1016\/j.antiviral.2014.08.016_b0160","doi-asserted-by":"crossref","first-page":"11686","DOI":"10.1128\/JVI.01694-12","article-title":"A virus-like particle that elicits cross-reactive antibodies to the conserved stem of influenza virus hemagglutinin","volume":"86","author":"Schneemann","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.08.016_b0165","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1074\/jbc.M210665200","article-title":"The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity","volume":"278","author":"Shinkawa","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.08.016_b0170","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1086\/315320","article-title":"The impact of influenza epidemics on hospitalizations","volume":"181","author":"Simonsen","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2014.08.016_b0175","doi-asserted-by":"crossref","first-page":"e00018","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2014.08.016_b0180","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.antiviral.2008.06.014","article-title":"Evaluation of intravenous zanamivir against experimental influenza A (H5N1) virus infection in cynomolgus macaques","volume":"80","author":"Stittelaar","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.08.016_b0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2014.08.016_b0190","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2014.08.016_b0195","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fimmu.2012.00087","article-title":"Pandemic H1N1 influenza infection and vaccination in humans induces cross-protective antibodies that target the hemagglutinin stem","volume":"3","author":"Thomson","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2014.08.016_b0200","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.antiviral.2014.08.016_b0205","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1440-1843.2008.01246.x","article-title":"Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses","volume":"13","author":"Uyeki","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.antiviral.2014.08.016_b0210","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4049\/jimmunol.115.2.434","article-title":"Host defenses against influenza virus: the role of anti-hemagglutinin antibody","volume":"115","author":"Virelizier","year":"1975","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2014.08.016_b0215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2008.06.002","article-title":"Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein","volume":"80","author":"Wang","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.08.016_b0220","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/JVI.62.8.2762-2772.1988","article-title":"Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions","volume":"62","author":"Zebedee","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.08.016_b0225","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1128\/JVI.79.11.6644-6654.2005","article-title":"Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2","volume":"79","author":"Zharikova","year":"2005","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T15:18:01Z","timestamp":1689520681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214002538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":45,"alternative-id":["S0166354214002538"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.08.016","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of a fully human monoclonal antibody against multiple influenza A viral strains in mice and a pandemic H1N1 strain in nonhuman primates","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}